These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12427610)

  • 41. Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
    Qualliotine JR; Mydlarz WK; Chan JY; Zhou X; Wang H; Agrawal N
    J Laryngol Otol; 2015 Dec; 129(12):1213-9. PubMed ID: 26490394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing the resectability of pancreatic carcinoma: the value of reinterpreting abdominal CT performed at other institutions.
    Kalbhen CL; Yetter EM; Olson MC; Posniak HV; Aranha GV
    AJR Am J Roentgenol; 1998 Dec; 171(6):1571-6. PubMed ID: 9843290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival After Distant Metastasis in Head and Neck Cancer.
    Wiegand S; Zimmermann A; Wilhelm T; Werner JA
    Anticancer Res; 2015 Oct; 35(10):5499-502. PubMed ID: 26408715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of the head and neck surgeon in contemporary multidisciplinary treatment programs for advanced head and neck cancer.
    Wong RJ; Shah JP
    Curr Opin Otolaryngol Head Neck Surg; 2010 Apr; 18(2):79-82. PubMed ID: 20168233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
    Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K
    AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factor analysis of medical image sequences in MR of head and neck tumors.
    Zagdanski AM; Sigal R; Bosq J; Bazin JP; Vanel D; Di Paola R
    AJNR Am J Neuroradiol; 1994 Aug; 15(7):1359-68. PubMed ID: 7976950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
    Meerwein CM; Queiroz M; Kollias S; Hüllner M; Veit-Haibach P; Huber GF
    Swiss Med Wkly; 2015; 145():w14116. PubMed ID: 25701645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI.
    Kanda T; Kitajima K; Suenaga Y; Konishi J; Sasaki R; Morimoto K; Saito M; Otsuki N; Nibu K; Sugimura K
    Eur J Radiol; 2013 Nov; 82(11):2005-10. PubMed ID: 23891295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevertebral space invasion in head and neck cancer: negative predictive value of imaging techniques.
    Imre A; Pinar E; Erdoğan N; Ece AA; Olgun Y; Aladag I; Ozturkcan S
    Ann Otol Rhinol Laryngol; 2015 May; 124(5):378-83. PubMed ID: 25416240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Malignant melanoma of the head and neck: presentation of three cases and review of the literature.
    Yu E; Kassel EE; Irish J; O'Sullivan B; Bartlett E
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):E138-42. PubMed ID: 19128658
    [No Abstract]   [Full Text] [Related]  

  • 52. Can adaptive threshold-based metabolic tumor volume (MTV) and lean body mass corrected standard uptake value (SUL) predict prognosis in head and neck cancer patients treated with definitive radiotherapy/chemoradiotherapy?
    Akagunduz OO; Savas R; Yalman D; Kocacelebi K; Esassolak M
    Nucl Med Biol; 2015 Nov; 42(11):899-904. PubMed ID: 26275933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Standardized uptake value and resection margin involvement predict outcomes in pN0 head and neck cancer.
    Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
    Otolaryngol Head Neck Surg; 2013 Nov; 149(5):721-6. PubMed ID: 23921497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TNM staging with FDG-PET/CT in patients with primary head and neck cancer.
    Veit-Haibach P; Luczak C; Wanke I; Fischer M; Egelhof T; Beyer T; Dahmen G; Bockisch A; Rosenbaum S; Antoch G
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1953-62. PubMed ID: 17717661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?
    Narayan K; Crane CH; Kleid S; Hughes PG; Peters LJ
    Head Neck; 1999 Oct; 21(7):606-13. PubMed ID: 10487947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imaging of cervical lymph nodes in head and neck cancer: the basics.
    Gor DM; Langer JE; Loevner LA
    Radiol Clin North Am; 2006 Jan; 44(1):101-10, viii. PubMed ID: 16297684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
    Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
    Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer.
    Gourin CG; Williams HT; Seabolt WN; Herdman AV; Howington JW; Terris DJ
    Laryngoscope; 2006 May; 116(5):705-10. PubMed ID: 16652075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning.
    Dirix P; Vandecaveye V; De Keyzer F; Op de Beeck K; Poorten VV; Delaere P; Verbeken E; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):761-6. PubMed ID: 19540069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [TMN classification of hypopharynx carcinoma - hypopharynx carcinoma: TNM classification].
    Reimann K; Horger M; Schulze M
    Rofo; 2013 Dec; 185(12):1119-23. PubMed ID: 24318143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.